Table of Contents
International Journal of Inorganic Chemistry
Volume 2010 (2010), Article ID 975756, 7 pages
http://dx.doi.org/10.1155/2010/975756
Research Article

Reaction of the Anticancer Organometallic Ruthenium Compound, [(-Cymene)Ru(ATSC)Cl] with Human Serum Albumin

Science Division, Lyon College, 2300 Highland Road, Batesville, AR 72501, USA

Received 8 September 2009; Accepted 6 November 2009

Academic Editor: Stephen Ralph

Copyright © 2010 Floyd A. Beckford. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Sava, S. Pacor, A. Bergamo, M. Cocchietto, G. Mestroni, and E. Alessio, “Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition,” Chemico-Biological Interactions, vol. 95, no. 1-2, pp. 109–126, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Sava and A. Bergamo, “Ruthenium-based compounds and tumour growth control (review),” International Journal of Oncology, vol. 17, no. 2, pp. 353–365, 2000. View at Google Scholar · View at Scopus
  3. J. M. Rademaker-Lakhai, D. van den Bongard, D. Pluim, J. H. Beijnen, and J. H. Schellens, “A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent,” Clinical Cancer Research, vol. 10, no. 11, pp. 3717–3727, 2004. View at Publisher · View at Google Scholar
  4. G. Sava, R. Gagliardi, A. Bergamo, E. Alessio, and G. Mestroni, “Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine,” Anticancer Research, vol. 19, no. 2, pp. 969–972, 1999. View at Google Scholar · View at Scopus
  5. A. Bergamo, B. Gava, E. Alessio et al., “Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity,” International Journal of Oncology, vol. 21, no. 6, pp. 1331–1338, 2002. View at Google Scholar · View at Scopus
  6. C. G. Hartinger, S. Zorbas-Seifried, M. A. Jakupec, B. Kynast, H. Zorbas, and B. K. Keppler, “From bench to bedside—preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A),” Journal of Inorganic Biochemistry, vol. 100, no. 5-6, pp. 891–904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Kapitza, M. Pongratz, M. A. Jakupec et al., “Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells,” Journal of Cancer Research and Clinical Oncology, vol. 131, no. 2, pp. 101–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. E. D. Kreuser, B. K. Keppler, W. E. Berdel, A. Piest, and E. Thiel, “Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines,” Seminars in Oncology, vol. 19, no. 2, supplement 3, pp. 73–81, 1992. View at Google Scholar · View at Scopus
  9. R. E. Morris, R. E. Aird, P. Murdoch et al., “Inhibition of cancer cell growth by ruthenium(II) arene complexes,” Journal of Medicinal Chemistry, vol. 44, no. 22, pp. 3616–3621, 2001. View at Publisher · View at Google Scholar
  10. O. Novakova, J. Kasparkova, V. Bursova et al., “Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity,” Chemistry & Biology, vol. 12, no. 1, pp. 121–129, 2005. View at Google Scholar
  11. A. Casini, A. Guerri, C. Gabbiani, and L. Messori, “Biophysical characterization of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies,” Journal of Inorganic Biochemistry, vol. 108, no. 5-6, pp. 995–1006, 2002. View at Google Scholar
  12. J. Will, A. Kyas, W. S. Sheldrick, and D. Wolters, “Identification of (η6-arene)ruthenium(II) protein binding sites in E. coli cells by combined multidimensional liquid chromatography and ESI tandem mass spectrometry: specific binding of [(η6-p-cymene)RuCl2(DMSO)] to stress-regulated proteins and to helicases,” Journal of Biological Inorganic Chemistry, vol. 12, no. 6, pp. 883–894, 2007. View at Google Scholar
  13. A. Casini, G. Mastrobuoni, M. Terenghi et al., “Ruthenium anticancer drugs and proteins: a study of the interactions of the ruthenium(III) complex imidazolium trans-[tetrachloro(dimethyl sulfoxide)(imidazole)ruthenate(III)] with hen egg white lysozyme and horse heart cytochrome c,” Journal of Biological Inorganic Chemistry, vol. 12, no. 8, pp. 1107–1117, 2007. View at Publisher · View at Google Scholar
  14. A. Casini, C. Gabbiani, E. Michelucci et al., “Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound,” Journal of Biological Inorganic Chemistry, vol. 14, no. 5, pp. 761–770, 2009. View at Publisher · View at Google Scholar
  15. P. A. Zunszain, J. Ghuman, T. Komatsu, E. Tsuchida, and S. Curry, “Crystal structural analysis of human serum albumin complexed with hemin and fatty acid,” BMC Structural Biology, vol. 3, article 6, 2003. View at Publisher · View at Google Scholar
  16. B. Honore, “Conformational changes in human serum albumin induced by ligand binding,” Pharmacology and Toxicology, vol. 66, supplement 2, pp. 7–26, 1990. View at Google Scholar · View at Scopus
  17. F. A. Beckford, G. Leblanc, J. Thessing et al., “Organometallic ruthenium complexes with thiosemicarbazone ligands: synthesis, structure and cytotoxicity of [(?6-p-cymene)Ru(NS)CI]+ (NS = 9-anthraldehyde thiosemicarbazones),” Inorganic Chemistry Communications, vol. 12, no. 11, pp. 1094–1098, 2009. View at Publisher · View at Google Scholar
  18. S. Krimm and J. Bandekar, “Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins,” Advances in Protein Chemistry, vol. 38, pp. 181–364, 1986. View at Google Scholar · View at Scopus
  19. J.-S. Mandeville, E. Froehlich, and H. A. Tajmir-Riahi, “Study of curcumin and genistein interactions with human serum albumin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 49, no. 2, pp. 468–474, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. R. Lakowicz and J. G. Weber, “Quenching of fluorescence by oxygen. Probe for structural fluctuations in macromolecules,” Biochemistry, vol. 12, no. 21, pp. 4161–4170, 1973. View at Publisher · View at Google Scholar
  21. W. R. Ware, “Oxygen quenching of fluorescence in solution: an experimental study of the diffusion process,” The Journal of Physical Chemistry, vol. 66, no. 3, pp. 455–458, 1962. View at Publisher · View at Google Scholar
  22. S.-S. Wu, W.-B. Yuan, H.-Y. Wang, Q. Zhang, M. Liu, and K.-B. Yu, “Synthesis, crystal structure and interaction with DNA and HSA of (N,N-dibenzylethane-1,2-diamine) transition metal complexes,” Journal of Inorganic Biochemistry, vol. 102, no. 11, pp. 2026–2034, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. S. Aleksenko, C. G. Hartinger, O. Semenova, K. Meelich, A. R. Timerbaev, and B. K. Keppler, “Characterization of interactions between human serum albumin and tumor-inhibiting amino alcohol platinum(II) complexes using capillary electrophoresis,” Journal of Chromatography A, vol. 1155, no. 2, pp. 218–221, 2007. View at Publisher · View at Google Scholar
  24. P. D. Ross and S. Subramanian, “Thermodynamics of protein association reactions: forces contributing to stability,” Biochemistry, vol. 20, no. 11, pp. 3096–3102, 1981. View at Google Scholar · View at Scopus
  25. O. Novakova, H. Chen, O. Vrana, A. Rodger, P. J. Sadler, and V. Brabec, “DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free medial,” Biochemistry, vol. 42, no. 39, pp. 11544–11554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. D. M. Byler and H. Susi, “Examination of the secondary structure of proteins by deconvolved FTIR spectra,” Biopolymers, vol. 25, no. 3, pp. 469–487, 1986. View at Google Scholar · View at Scopus